Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-02-05 02:10 | 2015-02-02 | MSFT | MICROSOFT CORP | Morfit G Mason | Director, Other | Services-Prepackaged Software | BUY | $41.15 | 1,032,258 | $42,477,210 | 67,900,000 | +1.5% |
| 2015-02-05 01:19 | 2015-02-03 | ENTL | N/A | Split Rock Partners, LP | 10% owner | Other | BUY | $17.00 | 352,941 | $5,999,997 | 3,156,731 | +12.6% |
| 2015-02-05 00:58 | 2015-02-03 | ENTL | N/A | SVLSF IV, LLC | 10% owner | Other | BUY | $17.00 | 317,647 | $5,399,999 | 59,350 | +100.0% |
| 2015-02-05 00:16 | 2015-02-02 | FONU | N/A | Hameed Yusuf | 10% owner | Other | BUY | $149.00 | 1,488,002 | $221,712,298 | 116,488,002 | +1.3% |
| 2015-02-05 00:21 | 2015-02-03 | FDBC | FIDELITY D & D BANCORP INC | CALI BRIAN J | Director | National Commercial Banks | BUY | $32.25 | 186,263 | $6,006,994 | 186,663 | +46,565.8% |
| 2015-02-05 00:10 | 2015-02-03 | FDBC | FIDELITY D & D BANCORP INC | DEMPSEY PATRICK J | Director, Other | National Commercial Banks | BUY | $32.25 | 65,371 | $2,108,203 | 65,771 | +16,342.7% |
| 2015-02-04 00:17 | 2015-02-03 | LENS | N/A | RESSLER RICHARD S | Director, 10% owner | Other | BUY | $10.00 | 500,000 | $5,000,000 | 9,666,667 | +5.5% |
| 2015-02-04 00:27 | 2015-01-30 | N/A | N/A | NexPoint Advisors, L.P. | 10% owner, Other | Other | BUY | $9.20 | 336,957 | $3,100,000 | 1,724,891 | +24.3% |
| 2015-02-03 20:05 | 2014-03-12 | AQXP | Neurogene Inc. | JOHNSON & JOHNSON | 10% owner | Pharmaceutical Preparations | BUY | $11.00 | 272,727 | $2,999,997 | 1,664,821 | +19.6% |
| 2015-02-04 00:55 | 2015-02-03 | GDOT | GREEN DOT CORP | Streit Steven W | Director, Officer, 10% owner - Chairman, President and CEO | Finance Services | BUY | $14.45 | 206,800 | $2,988,260 | 3,528,355 | +6.2% |
| 2015-02-04 02:37 | 2015-01-30 | BH | N/A | BIGLARI, SARDAR | Director, Officer, 10% owner - Chairman and CEO | Other | BUY | $411.87 | 2,566 | $1,056,853 | 349,593 | +0.7% |
| 2015-02-04 00:26 | 2015-01-30 | N/A | N/A | DONDERO JAMES D | Officer, 10% owner - President | Other | BUY | $9.20 | 336,957 | $3,100,000 | 1,724,891 | +24.3% |
| 2015-02-03 18:42 | 2015-02-02 | HES | N/A | HESS JOHN B | Director, Officer, 10% owner - Chief Executive Officer | Other | BUY | $69.52 | 57,506 | $3,997,817 | 28,753 | +100.0% |
| 2015-02-03 01:48 | 2015-01-29 | EGLE | N/A | GOLDENTREE ASSET MANAGEMENT LP | 10% owner | Other | BUY | $9.66 | 565,000 | $5,459,991 | 5,048,448 | +12.6% |
| 2015-02-03 02:07 | 2015-01-29 | SHLD | N/A | BERKOWITZ BRUCE R | 10% owner | Other | BUY | $32.18 | 32,200 | $1,036,051 | 25,473,073 | +0.1% |
| 2015-02-02 21:10 | 2015-01-29 | ALNY | Alnylam Pharmaceuticals Inc. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $95.00 | 97,118 | $9,226,210 | 10,051,603 | +1.0% |
| 2015-02-02 19:53 | 2015-01-22 | ALNY | Alnylam Pharmaceuticals Inc. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $93.17 | 196,251 | $18,284,706 | 9,307,037 | +2.2% |
| 2015-02-03 01:33 | 2015-01-29 | MRTX | N/A | BAKER BROS. ADVISORS LP | 10% owner | Other | BUY | $20.00 | 425,000 | $8,500,000 | 2,604,832 | +19.5% |
| 2015-02-03 00:55 | 2015-01-29 | MRTX | N/A | Boxer Capital, LLC | 10% owner | Other | BUY | $20.00 | 550,000 | $11,000,000 | 500,000 | +100.0% |
| 2015-01-31 01:39 | 2013-10-25 | AERI | N/A | Clarus Lifesciences II, L.P. | 10% owner | Other | BUY | $10.00 | 321,000 | $3,210,000 | 3,468,494 | +10.2% |
| 2015-01-30 01:09 | 2015-01-27 | VSAR | Aravive, Inc. | SUN ANTHONY Y | Director | Pharmaceutical Preparations | BUY | $17.25 | 145,000 | $2,501,250 | 2,139,568 | +7.3% |
| 2015-01-30 01:38 | 2015-01-28 | BK | Bank of New York Mellon Corp | GARDEN EDWARD P | Director | State Commercial Banks | BUY | $36.63 | 273,000 | $9,999,499 | 29,170,639 | +0.9% |
| 2015-01-30 00:26 | 2015-01-27 | NHF | NEXPOINT DIVERSIFIED REAL ESTATE TRUST | DONDERO JAMES D | Other | Real Estate Investment Trusts | BUY | $11.32 | 102,210 | $1,157,156 | 4,715,508 | +2.2% |
| 2015-01-30 01:10 | 2015-01-27 | VSAR | Aravive, Inc. | AISLING CAPITAL III LP | 10% owner | Pharmaceutical Preparations | BUY | $17.25 | 145,000 | $2,501,250 | 2,139,568 | +7.3% |
| 2015-01-28 17:05 | 2015-01-27 | SSP | E.W. SCRIPPS Co | Scripps Eaton M | 10% owner | Television Broadcasting Stations | BUY | $16.72 | 82,651 | $1,381,925 | 617,317 | +15.5% |
| 2015-01-28 17:04 | 2015-01-27 | SNI | N/A | Scripps Eaton M | 10% owner | Other | BUY | $74.71 | 645,979 | $48,261,091 | 2,249,979 | +40.3% |
| 2015-01-28 17:00 | 2015-01-27 | SNI | N/A | Attal Eva Scripps | 10% owner | Other | BUY | $74.71 | 21,143 | $1,579,594 | 823,143 | +2.6% |
| 2015-01-28 22:16 | 2015-01-28 | VSTM | Verastem, Inc. | Westphal Christoph H | Director, Officer - Executive Chairman | Pharmaceutical Preparations | BUY | $6.50 | 1,230,769 | $7,999,999 | 1,230,769 | +100.0% |
| 2015-01-28 17:02 | 2015-01-27 | SSP | E.W. SCRIPPS Co | SCRIPPS EDWARD W | 10% owner | Television Broadcasting Stations | BUY | $16.72 | 82,650 | $1,381,908 | 617,316 | +15.5% |
| 2015-01-28 17:02 | 2015-01-27 | SNI | N/A | SCRIPPS EDWARD W | 10% owner | Other | BUY | $74.71 | 109,211 | $8,159,154 | 1,713,211 | +6.8% |
| 2015-01-28 16:58 | 2015-01-27 | SSP | E.W. SCRIPPS Co | SCRIPPS CHARLES E | 10% owner | Television Broadcasting Stations | BUY | $16.72 | 82,650 | $1,381,908 | 617,315 | +15.5% |
| 2015-01-28 14:51 | 2015-01-22 | ALNY | Alnylam Pharmaceuticals Inc. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $2,240.11 | 843,699 | $1,889,978,145 | 9,954,485 | +9.3% |
| 2015-01-28 21:54 | 2015-01-28 | ASPX | N/A | Flynn James E | 10% owner, Other | Other | BUY | $56.50 | 1,500,000 | $84,750,000 | 973,379 | +100.0% |
| 2015-01-28 00:25 | 2015-01-23 | AGRX | N/A | AISLING CAPITAL III LP | Director, 10% owner | Other | BUY | $5.85 | 811,966 | $4,750,001 | 2,983,797 | +37.4% |
| 2015-01-27 20:59 | 2015-01-27 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director, Officer, 10% owner - Chief Executive Officer | Pharmaceutical Preparations | BUY | $27.00 | 555,556 | $15,000,012 | 5,483,957 | +11.3% |
| 2015-01-28 03:05 | 2015-01-23 | OAS | Chord Energy Corp | SPO ADVISORY CORP | 10% owner | Crude Petroleum & Natural Gas | BUY | $13.24 | 1,000,000 | $13,240,000 | 12,472,400 | +8.7% |
| 2015-01-27 00:43 | 2015-01-22 | PN | N/A | Mariano Steven M. | Director, Officer, 10% owner - See Remarks | Other | BUY | $14.00 | 339,292 | $4,750,088 | 339,292 | +100.0% |
| 2015-01-27 01:54 | 2015-01-22 | CAS | N/A | MARTIN WILLIAM C | 10% owner | Other | BUY | $6.05 | 177,573 | $1,074,832 | 3,772,256 | +4.9% |
| 2015-01-24 02:05 | 2015-01-21 | CAPR | CAPRICOR THERAPEUTICS, INC. | St. John Edward A. | 10% owner | Pharmaceutical Preparations | BUY | $3.52 | 851,546 | $2,999,997 | 425,773 | +100.0% |
| 2015-01-24 00:54 | 2015-01-23 | AGRX | N/A | Moorin Jay | 10% owner | Other | BUY | $5.85 | 811,966 | $4,750,001 | 4,668,663 | +21.1% |
| 2015-01-23 04:42 | 2015-01-21 | CAPR | CAPRICOR THERAPEUTICS, INC. | CEDARS SINAI MEDICAL CENTER | 10% owner | Pharmaceutical Preparations | BUY | $3.52 | 851,546 | $2,999,997 | 2,175,632 | +64.3% |
| 2015-01-21 19:36 | 2014-12-19 | ASPS | ALTISOURCE PORTFOLIO SOLUTIONS S.A. | COOPERMAN LEON G | 10% owner | Services-Miscellaneous Business Services | BUY | $40.29 | 224,107 | $9,028,352 | 816,099 | +37.9% |
| 2015-01-21 22:11 | 2015-01-16 | ATLS | N/A | COOPERMAN LEON G | 10% owner | Other | BUY | $27.31 | 144,000 | $3,932,640 | 2,642,416 | +5.8% |
| 2015-01-22 03:32 | 2015-01-16 | CAS | N/A | MARTIN WILLIAM C | 10% owner | Other | BUY | $5.86 | 189,092 | $1,108,854 | 3,594,683 | +5.6% |
| 2015-01-21 02:10 | 2013-09-27 | ACHN | N/A | RA CAPITAL MANAGEMENT, LLC | Other | Other | BUY | $3.64 | 2,152,000 | $7,831,989 | 4,816,562 | +80.8% |
| 2015-01-21 02:09 | 2013-07-17 | ACHN | N/A | RA CAPITAL MANAGEMENT, LLC | Other | Other | BUY | $6.74 | 698,336 | $4,709,508 | 4,856,521 | +16.8% |
| 2015-01-21 00:38 | 2015-01-15 | WIA | WESTERN ASSET INFLATION-LINKED INCOME FUND | CASCADE INVESTMENT LLC | 10% owner | Other | BUY | $11.68 | 453,694 | $5,299,146 | 6,632,888 | +7.3% |
| 2015-01-21 00:35 | 2015-01-15 | WIW | WESTERN ASSET INFLATION-LINKED OPPORTUNITIES & INCOME FUND | CASCADE INVESTMENT LLC | 10% owner | Other | BUY | $11.41 | 408,000 | $4,655,280 | 12,580,489 | +3.4% |
| 2015-01-17 02:16 | 2015-01-14 | EHTH | eHealth, Inc. | Flynn James E | 10% owner, Other | Insurance Agents, Brokers & Service | BUY | $20.30 | 1,000,000 | $20,302,400 | 1,804,903 | +124.2% |
| 2015-01-16 00:32 | 2015-01-13 | OVAS | Tempest Therapeutics, Inc. | Malley Thomas | Director | Pharmaceutical Preparations | BUY | $50.00 | 35,000 | $1,750,000 | 116,819 | +42.8% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.